Tianjin Third Central Hospital
Tianjin Third Central Hospital
Tianjin, Tianjin Municipality, China3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Daridorexant for Sleep Disturbance in Adults With Liver Cirrhosis | Brain Diseases, Metabolic, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Nutritional and Metabolic Diseases, Parasomnias, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, central nervous system disorder, cirrhosis of liver, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder, psychiatric disorder, sleep disorder, sleep-wake disorder | Not yet recruiting | Phase 4 | 2026-09-21 | NCT07830303 | |
| A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitis | Recruiting | Phase 3 | 2026-07-08 | NCT07282353 | |
| Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitis | Recruiting | Phase 2 / Phase 3 | 2026-01-08 | NCT05749822 |